LINC02392
gene geneOn this page
Also known as lncRNA-ECVSR
Summary
LINC02392 (long intergenic non-protein coding RNA 2392, HGNC:53319) is a long non-coding RNA gene on chromosome 12q21.33.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53319 |
| Approved symbol | LINC02392 |
| Name | long intergenic non-protein coding RNA 2392 |
| Location | 12q21.33 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | lncRNA-ECVSR |
| Ensembl gene | ENSG00000258183 |
| Ensembl biotype | lncRNA |
| Entrez | 105369893 |
| RNAcentral | URS0000A7673B — lncRNA, 879 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 lncRNA
ENST00000548172, ENST00000549313, ENST00000549470, ENST00000658748, ENST00000658788, ENST00000670390
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000548172 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002370194 | 90293323 | 90293560 |
| ENSE00002397120 | 90295357 | 90295492 |
| ENSE00002414238 | 90296085 | 90296247 |
Expression profiles
Bgee: expression breadth ubiquitous, 116 present calls, max score 77.20.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1244 / max 17.2896, expressed in 57 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127287 | 0.1244 | 57 |
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.20 | gold quality |
| stromal cell of endometrium | CL:0002255 | 68.29 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 67.84 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 66.85 | gold quality |
| sural nerve | UBERON:0015488 | 65.77 | silver quality |
| ventricular zone | UBERON:0003053 | 62.15 | gold quality |
| colonic epithelium | UBERON:0000397 | 61.03 | silver quality |
| bone marrow | UBERON:0002371 | 57.00 | gold quality |
| ganglionic eminence | UBERON:0004023 | 56.78 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 56.28 | silver quality |
| primary visual cortex | UBERON:0002436 | 56.18 | gold quality |
| islet of Langerhans | UBERON:0000006 | 54.83 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.91 | gold quality |
| lymph node | UBERON:0000029 | 52.74 | gold quality |
| blood | UBERON:0000178 | 52.70 | gold quality |
| monocyte | CL:0000576 | 51.94 | gold quality |
| endometrium | UBERON:0001295 | 51.73 | gold quality |
| calcaneal tendon | UBERON:0003701 | 51.52 | silver quality |
| duodenum | UBERON:0002114 | 50.81 | gold quality |
| gall bladder | UBERON:0002110 | 50.48 | gold quality |
| placenta | UBERON:0001987 | 50.35 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 50.17 | gold quality |
| muscle of leg | UBERON:0001383 | 49.27 | gold quality |
| liver | UBERON:0002107 | 48.95 | silver quality |
| gastrocnemius | UBERON:0001388 | 48.80 | gold quality |
| frontal cortex | UBERON:0001870 | 48.72 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 47.98 | gold quality |
| cortex of kidney | UBERON:0001225 | 47.32 | silver quality |
| heart left ventricle | UBERON:0002084 | 47.29 | gold quality |
| tibial nerve | UBERON:0001323 | 46.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.59 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.